AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial evaluates AI-assisted interactive case-based education for smoking cessation counseling among medical interns at Assiut University. Participants receive AI-enabled training that simulates clinical encounters and provides structured feedback based on the 5A framework. Pre- and post-training assessments measure changes in counseling performance. The study uses a straightforward interventional design with guided educational content and performance testing to determine effectiveness. No results are provided here, as the study is a protocol description and aims to generate evidence on this educational approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Medical interns enrolled in the internship training program at the Faculty of Medicine, Assiut University during the study period.
* Able to attend the training session and complete all study assessments, including the pre-test and post-test evaluations.

Exclusion Criteria:

* Previous formal structured training in smoking cessation counseling based on the 5A model.
* Previous participation in a smoking cessation counseling educational program within the preceding 12 months.
* Failure to complete the assigned educational intervention.
* Failure to complete either the pre-test or post-test assessment.
* Withdrawal of consent at any stage of the study.

Where it's running

• Assuit University Hospiatal
  Asyut, Assuit, Egypt Recruiting

Study contacts

• Principal investigator: waleed gamal, ass. prof — Assiut University
• Study coordinator: waleed gamal, ass. prof
• Email: waleedgamalddin@yahoo.com
• Phone: +201006519722

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Nicotine Orodispersible Tablet to Relieve Cravings in Smokers

  A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.

  Recruiting Phase 2 Kenvue Brands LLC · Mississauga, Ontario · NCT07893158

• Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking

  This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.

  Recruiting The University of Hong Kong · Hong Kong · NCT07826884

• NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05

  This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.

  Recruiting at 28 sites Phase 3 Axsome Therapeutics, Inc. · Phoenix, Arizona and 27 other locations · NCT07766655

• Tirzepatide for Smoking Cessation in people who smoke and are overweight or obese

  This study tests whether tirzepatide can help adults who smoke quit and manage weight better than placebo when combined with usual smoking-cessation support.

  Recruiting at 4 sites Phase 2 University of Southern California · Los Angeles, California and 3 other locations · NCT07602699

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.